← Stock Trading Canary · All insider profiles
INSIDER PROFILE · SE
Peter Ostler
Styrelseledamot | Styrelseordförande
Profile key: se|peter ostler
Purchase history
- Companies traded
- 2
- Purchases · 12M
- 1
- Purchases · 24M
- 8
- Average purchase
- SEK 237,214
- Gross purchase value
- SEK 1,897,711
- Last purchase
- 2025-12-18
- Completed 20D events
- 8.0
- Outcome status
- PASS
Latest company: Alligator Bioscience AB
Companies: Alligator Bioscience AB | Hoodin AB
Post-purchase outcomes
Benchmark-relative outcomes are available against OMX Stockholm 30.
- Excess return = stock return − OMX Stockholm 30 return over the same period.
- Hit rate = positive excess-return events ÷ completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 8Developing | 100.0% (8/8) | 37.5% (3/8) | -6.6% | -21.5% | -80.5% |
| 20D | 8Developing | 100.0% (8/8) | 50.0% (4/8) | -22.8% | -30.7% | -78.2% |
| 60D | 8Developing | 100.0% (8/8) | 12.5% (1/8) | -66.3% | -48.9% | -97.5% |
| 120D | 8Developing | 100.0% (8/8) | 0.0% (0/8) | -77.3% | -80.1% | -112.3% |
Research patterns
- First purchase in 12M
- 1/5
- Large purchase ≥ €100k
- 0/8
- Cluster buying · 15D
- 4/8
- Buying the dip · ≥20% below prior 52W high
- 8/8
- Routine / opportunistic
- Not classifiable
Counts are profile-wide, point-in-time research labels. They never affect the insider score or ranking.
Every completed outcome is shown; n<5 is descriptive small-sample evidence and is not scored. Disclosure-level observations published on the same date may share a return path and may not be statistically independent. These results never affect the insider score or ranking.